PORGADOR; Angel

Patent Applications and Registrations

Patent applications and USPTO patent grants for PORGADOR; Angel.The latest application filed is for "il-2 chimeric proteins for immunosuppression".

Company Profile

2.8.14

PORGADOR; Angel - Lehavim IL
Porgador; Angel - Lehavia IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Il-2 Chimeric Proteins For Immunosuppression App 20220213163 - PORGADOR; Angel	2022-07-07
Tumor Environment-specific Expression Of Chimeric Antigen Receptors App 20210030799 - PORGADOR; Angel ; et al.	2021-02-04
Non-cytotoxic Modified Cells And Use Thereof App 20190233516 - MONSONEGO; Alon ; et al.	2019-08-01
Diagnostic and therapeutic methods and their application in amyotrophic lateral sclerosis (ALS) Grant 9,861,686 - Porgador , et al. January 9, 2	2018-01-09
Peptides derived from cytotoxicity receptor natural killer protein 44 NKP44 Grant 9,399,667 - Porgador July 26, 2	2016-07-26
Peptides Derived From Nkp44 App 20150105334 - PORGADOR; Angel	2015-04-16
Method of treating type 1 diabetes by administering NKp46 polypeptide Grant 8,980,244 - Mandelboim , et al. March 17, 2	2015-03-17
Diagnostic and Therapeutic Methods and Their Application in Amyotrophic Lateral Sclerosis (ALS) App 20140328824 - Porgador; Angel	2014-11-06
Compositions Of Hsp60 Peptides And Viral Antigens For Vaccination And Diagnosis App 20140120126 - Cohen; Irun R. ; et al.	2014-05-01
Compositions of HSP60 peptides and viral antigens for vaccination and diagnosis Grant 8,652,439 - Cohen , et al. February 18, 2	2014-02-18
Method For Treating Type 1 Diabetes App 20130280209 - MANDELBOIM; Ofer ; et al.	2013-10-24
Method of treating diabetes by administering an anti-NKp46 antibody Grant 8,420,092 - Mandelboim , et al. April 16, 2	2013-04-16
Use Of Nkp46 For Preventing Diabetes App 20120076753 - Mandelboim; Ofer ; et al.	2012-03-29
Compositions Of Hsp60 Peptides And Viral Antigens For Vaccination And Diagnosis App 20110256165 - Cohen; Irun R. ; et al.	2011-10-20
Fragments of NKp44 and NKp46 for targeting viral-infected and tumor cells Grant 7,825,085 - Mandelboim , et al. November 2, 2	2010-11-02
NK Cell Receptor Conjugates for Treating Malignancies App 20100047169 - MANDELBOIM; Ofer ; et al.	2010-02-25
Compositions of Hsp60 Peptides and Viral Antigens for Vaccination and Diagnosis App 20080279878 - Cohen; Irun R. ; et al.	2008-11-13
Peptides Derived from Natural Cytotoxicity Receptors and Methods of Use Thereof App 20070280938 - Mandelboim; Ofer ; et al.	2007-12-06
Nk cell receptor conjugates for treating malignancies App 20060165592 - Mandelboim; Ofer ; et al.	2006-07-27
Nk cells activiating receptors and their therapeutic and diagnostic uses App 20040072256 - Mandelboim, Ofer ; et al.	2004-04-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.